CA2257240A1 - Fragments de leptine (proteine ob) - Google Patents

Fragments de leptine (proteine ob) Download PDF

Info

Publication number
CA2257240A1
CA2257240A1 CA002257240A CA2257240A CA2257240A1 CA 2257240 A1 CA2257240 A1 CA 2257240A1 CA 002257240 A CA002257240 A CA 002257240A CA 2257240 A CA2257240 A CA 2257240A CA 2257240 A1 CA2257240 A1 CA 2257240A1
Authority
CA
Canada
Prior art keywords
peptide
host cell
peptides
dna
functional derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002257240A
Other languages
English (en)
Inventor
Kamal A. Al-Barazanji
Jonathan Robert Sanders Arch
Patrick Camilleri
William Arthur Neville
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9611775.9A external-priority patent/GB9611775D0/en
Priority claimed from GBGB9618540.0A external-priority patent/GB9618540D0/en
Priority claimed from GBGB9703493.8A external-priority patent/GB9703493D0/en
Application filed by Individual filed Critical Individual
Publication of CA2257240A1 publication Critical patent/CA2257240A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne une leptine, un peptide ob, ou un dérivé fonctionnel, un analogue ou un variant de ceux-ci, modulant le poids corporel essentiellement au moyen d'une modulation de l'utilisation de l'énergie. Elle concerne également une composition pharmaceutique contenant un tel composé, un procédé de préparation de celui-ci, ainsi que l'utilisation de ce composé en médecine.
CA002257240A 1996-06-06 1997-06-04 Fragments de leptine (proteine ob) Abandoned CA2257240A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9611775.9A GB9611775D0 (en) 1996-06-06 1996-06-06 Novel compounds
GB9611775.9 1996-06-06
GBGB9618540.0A GB9618540D0 (en) 1996-09-05 1996-09-05 Novel compounds
GB9618540.0 1996-09-05
GBGB9703493.8A GB9703493D0 (en) 1997-02-20 1997-02-20 Novel compounds
GB9703493.8 1997-02-20
PCT/EP1997/002968 WO1997046585A2 (fr) 1996-06-06 1997-06-04 Fragments de leptine (proteine ob)

Publications (1)

Publication Number Publication Date
CA2257240A1 true CA2257240A1 (fr) 1997-12-11

Family

ID=27268305

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002257240A Abandoned CA2257240A1 (fr) 1996-06-06 1997-06-04 Fragments de leptine (proteine ob)

Country Status (15)

Country Link
EP (1) EP0912609A2 (fr)
JP (1) JP2000512137A (fr)
KR (1) KR20000016402A (fr)
CN (1) CN1221426A (fr)
AR (1) AR008765A1 (fr)
AU (1) AU3337297A (fr)
BR (1) BR9709529A (fr)
CA (1) CA2257240A1 (fr)
CZ (1) CZ397898A3 (fr)
IL (1) IL127153A0 (fr)
NO (1) NO985683D0 (fr)
NZ (1) NZ332879A (fr)
PL (1) PL330361A1 (fr)
TR (1) TR199802534T2 (fr)
WO (1) WO1997046585A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2335107C (fr) 1998-07-28 2010-01-19 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Induction de genes a mediation par la leptine
US7208572B2 (en) * 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
AU782230B2 (en) * 1999-09-22 2005-07-14 Serono Genetics Institute S.A. Methods of screening for compounds that modulate the LSR-leptin interaction and their use in the prevention and treatment of obesity-related diseases
JP4756813B2 (ja) 2000-05-22 2011-08-24 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） レセプターを用いた相互作用の捕捉法
PT2219031E (pt) 2001-10-22 2013-05-17 Amgen Inc Uso de leptina para tratamento de lipoatrofia humana e método para determinar predisposição ao referido tratamento
AU2004269927B2 (en) 2003-09-08 2009-09-17 Merck Serono Sa Treatment of fibrotic disease
KR20120034237A (ko) 2004-02-11 2012-04-10 아밀린 파마슈티칼스, 인크. 선택가능한 특성을 갖는 하이브리드 폴리펩티드
CA2585549A1 (fr) 2004-11-18 2006-05-26 Vib Vzw Domaine de fibronectine iii servant d'antagonistes de recepteurs de la leptine
BRPI0606992A2 (pt) 2005-02-11 2009-07-28 Amylin Pharmaceuticals Inc análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis
US7629315B2 (en) 2005-03-09 2009-12-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compositions for blocking the inhibitory effect of human CRP on human leptin
EP2330124B1 (fr) 2005-08-11 2015-02-25 Amylin Pharmaceuticals, LLC Polypeptides hybrides ayant des propriétés sélectionnables
BRPI0614649A2 (pt) 2005-08-11 2011-04-12 Amylin Pharmaceuticals Inc polipeptìdeos hìbridos com propriedades selecionáveis
ES2319048B1 (es) * 2007-06-20 2010-02-10 Universitat De Les Illes Balears Uso de leptina en el tratamiento de alteraciones en los habitos alimentarios.
US8889622B2 (en) 2007-07-25 2014-11-18 Washington University Methods of inhibiting seizure in a subject
GB2451858A (en) * 2007-08-15 2009-02-18 Sergiy Konovchuk Methods of reducing body fat and treating obesity
EP2229362A1 (fr) 2007-12-05 2010-09-22 AstraZeneca AB Pipérazines comme agents anti-obésité
CN102015668A (zh) 2007-12-05 2011-04-13 阿斯利康(瑞典)有限公司 用作瘦蛋白受体调节剂的哌嗪衍生物及其用途
AU2009254547A1 (en) * 2008-06-04 2009-12-10 Astrazeneca Ab (Publ) New compounds V
CN102143747A (zh) * 2008-06-04 2011-08-03 阿斯利康(瑞典)有限公司 作为瘦蛋白受体调节剂模拟物的新的吡啶衍生物
JP2012523434A (ja) 2009-04-10 2012-10-04 アミリン・ファーマシューティカルズ，インコーポレイテッド エストロゲン欠乏哺乳類のためのアミリンアゴニスト化合物
EP2569326B1 (fr) * 2010-05-11 2016-08-10 The U.S.A. as represented by the Secretary, Department of Health and Human Services Inhibiteur peptidique de la signalisation de l'interleukine-10 ou de l'activation de stat-3
CA2813038C (fr) 2010-09-28 2021-12-28 Amylin Pharmaceuticals, Llc Leptines hautement solubles
CN104829707B (zh) * 2015-05-06 2017-12-19 广东省生物资源应用研究所 一条cd环和e螺旋区突变的瘦素活性肽及其编码基因和应用
CN110183530A (zh) * 2019-06-21 2019-08-30 深圳市亚辉龙生物科技股份有限公司 瘦素免疫原、杂交瘤细胞、单克隆抗体、多克隆抗体及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5552523A (en) * 1995-01-31 1996-09-03 Eli Lilly And Company Anti-obesity proteins
WO1996023815A1 (fr) * 1995-01-31 1996-08-08 Eli Lilly And Company Anticorps contre les produits du gene ob
WO1996023514A1 (fr) * 1995-01-31 1996-08-08 Eli Lilly And Company Proteines anti-obesite
WO1996031526A1 (fr) * 1995-04-06 1996-10-10 Amylin Pharmaceuticals, Inc. Agents antiobesite
GB9509164D0 (en) * 1995-05-05 1995-06-28 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
JP2000512137A (ja) 2000-09-19
NO985683L (no) 1998-12-04
WO1997046585A2 (fr) 1997-12-11
EP0912609A2 (fr) 1999-05-06
NO985683D0 (no) 1998-12-04
PL330361A1 (en) 1999-05-10
CZ397898A3 (cs) 1999-04-14
AU3337297A (en) 1998-01-05
BR9709529A (pt) 1999-08-10
TR199802534T2 (xx) 1999-03-22
WO1997046585A3 (fr) 1998-04-23
IL127153A0 (en) 1999-09-22
KR20000016402A (ko) 2000-03-25
CN1221426A (zh) 1999-06-30
NZ332879A (en) 2000-09-29
AR008765A1 (es) 2000-02-23

Similar Documents

Publication Publication Date Title
CA2257240A1 (fr) Fragments de leptine (proteine ob)
US6187751B1 (en) Biologically active peptide of ob protein
EP0383472B1 (fr) Analogues d'insuline
CA1341638C (fr) Facteur de croissance des fibreblastes
CA2070503C (fr) Proinsuline a-c-b, sa methode de fabrication et son utilisation, et intermediaires dans la production d'insuline
JP3181918B2 (ja) 成長ホルモン放出特性を持つ化合物
US7459522B2 (en) Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use
US8487075B2 (en) Alpha-conotoxin peptides
CH688195A5 (de) Peptide mit PTH-aehnlicher Aktivitaet.
CA2224080C (fr) Facteur similaire a la relaxine, ses procedes et emplois
NO844422L (no) Nye polypeptider med alfa-amylasehemmende virkning, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater
US5530095A (en) Peptides of melanin concentrating hormone precursor
US20020037553A1 (en) Fragments of leptin (ob protein)
WO2002064740A2 (fr) Peptides de cones
EP0269299A2 (fr) Peptides atriaux
US5965698A (en) Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US6153738A (en) Contryphan peptides
US6855805B2 (en) α-conotoxin peptides
JP2002534996A (ja) アルファ−コノトキシン・ペプチド
EP0672056B1 (fr) Polypeptides isoles du venin de filistata hibernalis destines a bloquer les canaux du calcium
AU7196200A (en) Fragments of leptin (ob protein)
AU773969B2 (en) Novel tachykinin peptides, precursor peptides thereof and genes encoding the same
CA2067304A1 (fr) Analogues de grf superactifs
AU2007285045A1 (en) Cardioprotective compounds
AU2002253924A1 (en) Cone snail peptides

Legal Events

Date Code Title Description
FZDE Discontinued